Bank of New York Mellon Corp Raises Stake in The Clorox Company $CLX

Bank of New York Mellon Corp boosted its stake in The Clorox Company (NYSE:CLX) by 2.3% in the 1st quarter, Holdings Channel reports. The firm owned 1,280,226 shares of the company’s stock after acquiring an additional 29,181 shares during the quarter. Bank of New York Mellon Corp’s holdings in Clorox were worth $132,670,000 at the end of the most recent reporting period.

Other hedge funds have also added to or reduced their stakes in the company. Blackhawk Capital Partners LLC increased its position in shares of Clorox by 14.8% during the first quarter. Blackhawk Capital Partners LLC now owns 13,692 shares of the company’s stock valued at $1,419,000 after buying an additional 1,768 shares during the period. Geneos Wealth Management Inc. lifted its holdings in shares of Clorox by 9.3% in the first quarter. Geneos Wealth Management Inc. now owns 1,402 shares of the company’s stock worth $145,000 after buying an additional 119 shares in the last quarter. MASTERINVEST Kapitalanlage GmbH boosted its position in shares of Clorox by 24.8% in the first quarter. MASTERINVEST Kapitalanlage GmbH now owns 6,902 shares of the company’s stock valued at $715,000 after acquiring an additional 1,373 shares during the period. Sanctuary Advisors LLC boosted its position in shares of Clorox by 47.8% in the first quarter. Sanctuary Advisors LLC now owns 20,248 shares of the company’s stock valued at $2,098,000 after acquiring an additional 6,553 shares during the period. Finally, Sigma Planning Corp grew its stake in Clorox by 55.0% during the first quarter. Sigma Planning Corp now owns 29,650 shares of the company’s stock valued at $3,073,000 after acquiring an additional 10,522 shares in the last quarter. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Clorox Price Performance

Shares of Clorox stock opened at $96.13 on Monday. The Clorox Company has a 52-week low of $84.70 and a 52-week high of $132.03. The stock has a market capitalization of $11.62 billion, a price-to-earnings ratio of 15.61 and a beta of 0.54. The company has a fifty day moving average of $94.59 and a 200-day moving average of $104.04. The company has a debt-to-equity ratio of 27.03, a quick ratio of 0.65 and a current ratio of 0.84.

Clorox (NYSE:CLX) last issued its earnings results on Thursday, April 30th. The company reported $1.64 EPS for the quarter, topping analysts’ consensus estimates of $1.55 by $0.09. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The company had revenue of $1.67 billion for the quarter, compared to analysts’ expectations of $1.67 billion. During the same quarter last year, the company earned $1.45 EPS. The firm’s revenue was up .1% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. Equities research analysts expect that The Clorox Company will post 5.52 EPS for the current year.

Insider Activity at Clorox

In related news, Director Pierre R. Breber acquired 5,000 shares of the firm’s stock in a transaction dated Tuesday, May 5th. The shares were purchased at an average price of $85.82 per share, for a total transaction of $429,100.00. Following the completion of the acquisition, the director owned 18,000 shares in the company, valued at approximately $1,544,760. This represents a 38.46% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available at this link. Corporate insiders own 0.63% of the company’s stock.

Analysts Set New Price Targets

CLX has been the subject of a number of research analyst reports. Evercore reiterated an “underperform” rating and set a $110.00 price target on shares of Clorox in a research report on Friday, May 1st. UBS Group increased their target price on Clorox from $96.00 to $100.00 and gave the company a “neutral” rating in a research note on Thursday. BNP Paribas Exane lowered their price target on Clorox from $128.00 to $97.00 and set a “neutral” rating on the stock in a research report on Tuesday, May 12th. Royal Bank Of Canada dropped their price target on Clorox from $132.00 to $127.00 and set a “sector perform” rating for the company in a research note on Thursday, April 9th. Finally, Wells Fargo & Company cut their price objective on Clorox from $100.00 to $95.00 and set an “equal weight” rating for the company in a report on Monday, May 18th. One research analyst has rated the stock with a Buy rating, eleven have given a Hold rating and five have issued a Sell rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Reduce” and an average price target of $103.47.

Clorox Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.